News & Updates
Filter by Specialty:
HEART-FID confirms IV iron safety for HF but falls short in efficacy
The HEART-FID trial narrowly missed its primary endpoint, showing modest improvement in all-cause mortality, heart failure hospitalizations (hHF), and exercise function with ferric carboxymaltose (FCM) in HFrEF* patients with iron deficiency (ID).
HEART-FID confirms IV iron safety for HF but falls short in efficacy
11 Sep 2023
Dapagliflozin safe, effective in HF patients across global regions
Dapagliflozin for individuals with heart failure (HF) demonstrates consistent safety and efficacy across regions worldwide despite geographic differences in patient characteristics, background treatment, and event rates, reports a recent study.
Dapagliflozin safe, effective in HF patients across global regions
08 Sep 2023
Hydrocortisone cuts mortality risk in ICU patients with severe pneumonia
In patients admitted to the intensive care unit (ICU) for severe community-acquired pneumonia (CAP), those who received hydrocortisone had a lower mortality risk compared with those on placebo, findings from the CAPE COD* trial suggest.
Hydrocortisone cuts mortality risk in ICU patients with severe pneumonia
08 Sep 2023
Is marijuana good or bad for you?
An umbrella review of meta-analyses on cannabis studies reveals that this psychoactive drug, more popularly known as marijuana, is only effective among people with epilepsy and should be avoided by adolescents and young adults, those who are prone to or with mental health disorders, pregnant women, and those who are driving.